Month: June 2020

Jun 18 2020

Uncategorized

Young people with early psychosis may not require antipsychotic medications to recover

by Clinical Editor

No Comments

Researchers have found that some young people with early stage first episode psychosis (FEP) can experience reduced symptoms and improve functioning without antipsychotic medication when they are provided with psychological...

Jun 17 2020

Uncategorized

COVID-19 in People With Schizophrenia

by Clinical Editor

No Comments

Jeffrey Lieberman, MD, director of the New York State Psychiatric Institute and psychiatrist-in-chief at the Columbia University Medical Center of NewYork-Presbyterian Hospital, helps us understand …

Jun 17 2020

Uncategorized

A decrease in spontaneous activity in medial prefrontal cortex is associated with sustained hallucinations in chronic schizophrenia: An NIRS study

by Clinical Editor

No Comments

In functional imaging, accumulating evidence suggests that spontaneous activity decreases during the resting state in the core brain regions of the default-mode network [e.g. medial prefrontal cortex …

Jun 17 2020

Uncategorized

Schizophrenia and Travel

by Clinical Editor

No Comments

People with certain brain disorders like schizophrenia tend to engage in risky behavior. Additionally, major life events including travel to foreign places can worsen psychotic symptoms (1).

Jun 17 2020

Uncategorized

Dysregulation of peripheral expression of the YWHA genes during conversion to psychosis

by Clinical Editor

No Comments

We explored the peripheral-blood expression level of the seven YWHA genes in 92 young individuals at ultra-high risk for psychosis (UHR). During the study, 36 participants converted to psychosis …

Jun 17 2020

Uncategorized

Antipsychotic May Fill Schizophrenia

by Clinical Editor

No Comments

Adjunctive treatment with the atypical antipsychotic pimavanserin is associated with marked improvement in patients with schizophrenia who have predominantly negative symptoms, new research suggests.

Jun 16 2020

Uncategorized

COVID-19 in People With Schizophrenia

by Clinical Editor

No Comments

Jeffrey Lieberman, MD, director of the New York State Psychiatric Institute and psychiatrist-in-chief at the Columbia University Medical Center of NewYork-Presbyterian Hospital, helps us understand …

Jun 16 2020

Uncategorized

A decrease in spontaneous activity in medial prefrontal cortex is associated with sustained hallucinations in chronic schizophrenia: An NIRS study

by Clinical Editor

No Comments

In functional imaging, accumulating evidence suggests that spontaneous activity decreases during the resting state in the core brain regions of the default-mode network [e.g. medial prefrontal cortex …

Jun 16 2020

Uncategorized

Schizophrenia and Travel

by Clinical Editor

No Comments

People with certain brain disorders like schizophrenia tend to engage in risky behavior. Additionally, major life events including travel to foreign places can worsen psychotic symptoms (1).

Jun 16 2020

Uncategorized

Neurocrine Biosciences and Takeda Announce Collaboration to Develop and Commercialize Potential Therapies for Psychiatric Disorders

by Clinical Editor

No Comments

Neurocrine Biosciences and Takeda announced a strategic collaboration for compounds in Takeda’s early-to-mid-stage psychiatry pipeline.